Puma Biotechnology
PBYI

Puma Biotechnology (PBYI) analyst forecast and price target

Analyst forecast

Hold

Consensus of 1 analyst rating

Buy
0
Hold
1
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
TD CowenMaintainedHold$6.00 from $5.00Aug 7, 2026
HC Wainwright & Co.MaintainedBuy$7.00Feb 28, 2025
HC Wainwright & Co.MaintainedBuy$7.00Dec 23, 2024
HC Wainwright & Co.MaintainedBuy$7.00Nov 20, 2024
HC Wainwright & Co.MaintainedBuy$7.00Nov 8, 2024
HC Wainwright & Co.MaintainedBuy$7.00Aug 2, 2024
HC Wainwright & Co.MaintainedBuy$7.00Jul 26, 2024
HC Wainwright & Co.MaintainedBuy$7.00Jun 4, 2024
HC Wainwright & Co.MaintainedBuy$7.00Jun 3, 2024
HC Wainwright & Co.MaintainedBuy$7.00May 20, 2024
HC Wainwright & Co.MaintainedBuy$7.00May 3, 2024
HC Wainwright & Co.MaintainedBuy$7.00 from $8.00Mar 1, 2024
HC Wainwright & Co.MaintainedBuy$8.00Feb 13, 2024
HC Wainwright & Co.MaintainedBuy$8.00Sep 20, 2023
HC Wainwright & Co.MaintainedBuy$8.00Aug 4, 2023
HC Wainwright & Co.MaintainedBuy$8.00Jun 5, 2023
HC Wainwright & Co.MaintainedBuy$8.00May 5, 2023

Frequently asked questions

  • Is PBYI a buy, sell, or hold?

    Analysts covering Puma Biotechnology currently average a Hold rating: 0 buy, 1 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on PBYI?

    On Aug 7, 2026, TD Cowen maintained Puma Biotechnology at Hold with a price target of $6.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.